The Growth Track

1999-2004

• Revenue rose ᡇ% per year to $1.2 billion

• Net earnings grew ᡖ% per year

2005 and beyond

• Targeting $2 billion in revenues

• More targeted cancer treatments

• Emerging businesses

• Acquisitions and new markets

Previous slide

Next slide

Back to first slide

View graphic version